Search Results

FILTER BY

1 - 12 of 178 matches

Sort by:
  • NewsDaily News

    Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

    Michael O'Riordan

    June 4, 2025

  • NewsDaily News

    Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

    Michael O'Riordan

    April 22, 2025

  • NewsDaily News

    Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care

    Michael O'Riordan

    February 27, 2025

  • NewsDaily News

    ACC/AHA Release New Comprehensive ACS Guidelines

    Todd Neale

    February 27, 2025

  • NewsDaily News

    Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

    Michael O'Riordan

    February 5, 2025

  • NewsConference NewsAHA 2024

    Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III

    Caitlin E. Cox

    November 21, 2024

  • NewsConference NewsESC 2024

    Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

    Michael O'Riordan

    September 1, 2024

  • NewsConference NewsACC 2024

    NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

    Yael L. Maxwell

    July 3, 2024

  • NewsDaily News

    High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

    Michael O'Riordan

    February 29, 2024

  • NewsDaily News

    Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

    L.A. McKeown

    February 23, 2024

  • NewsDaily News

    Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

    Yael L. Maxwell

    February 15, 2024

  • NewsDaily News

    Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

    Michael O'Riordan

    February 8, 2024